Federated Hermes, Inc. Xencor Inc Transaction History

Federated Hermes, Inc.

  • $43.6 Billion
  • Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,521 shares of XNCR stock, worth $51,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,521
Holding current value
$51,957
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.7 - $21.65 $39,579 - $54,579
2,521 New
2,521 $50,000
Q4 2023

Jan 31, 2024
SELL
$16.53 - $21.42 $57,309 - $74,263
-3,467 Reduced 58.73%
2,436 $51,000
Q3 2023

Nov 13, 2023
SELL
$20.08 - $25.39 $12,570 - $15,894
-626 Reduced 9.59%
5,903 $118,000
Q2 2023

Aug 14, 2023
BUY
$24.77 - $29.9 $1,510 - $1,823
61 Added 0.94%
6,529 $163,000
Q1 2023

May 08, 2023
SELL
$25.95 - $36.95 $66,925 - $95,294
-2,579 Reduced 28.51%
6,468 $180,000
Q4 2022

Feb 13, 2023
SELL
$24.79 - $30.86 $34,606 - $43,080
-1,396 Reduced 13.37%
9,047 $235,000
Q3 2022

Nov 14, 2022
BUY
$24.62 - $32.44 $6,868 - $9,050
279 Added 2.74%
10,443 $271,000
Q2 2022

Aug 15, 2022
SELL
$19.74 - $29.01 $166,309 - $244,409
-8,425 Reduced 45.32%
10,164 $278,000
Q1 2022

May 13, 2022
SELL
$26.68 - $41.63 $2.61 Million - $4.07 Million
-97,870 Reduced 84.04%
18,589 $496,000
Q4 2021

Feb 14, 2022
SELL
$33.67 - $43.44 $1.3 Million - $1.68 Million
-38,600 Reduced 24.89%
116,459 $4.67 Million
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $103,290 - $120,241
-3,370 Reduced 2.13%
155,059 $5.06 Million
Q2 2021

Aug 16, 2021
SELL
$34.33 - $44.68 $423,494 - $551,172
-12,336 Reduced 7.22%
158,429 $5.46 Million
Q1 2021

May 13, 2021
SELL
$40.81 - $53.88 $266,122 - $351,351
-6,521 Reduced 3.68%
170,765 $7.35 Million
Q4 2020

Feb 12, 2021
SELL
$36.63 - $47.63 $1.6 Million - $2.08 Million
-43,580 Reduced 19.73%
177,286 $7.74 Million
Q3 2020

Nov 12, 2020
SELL
$30.09 - $43.02 $1.32 Million - $1.89 Million
-43,927 Reduced 16.59%
220,866 $8.57 Million
Q2 2020

Aug 13, 2020
SELL
$27.76 - $33.42 $3.52 Million - $4.23 Million
-126,645 Reduced 32.35%
264,793 $8.58 Million
Q1 2020

May 13, 2020
BUY
$20.69 - $37.79 $7.81 Million - $14.3 Million
377,435 Added 2695.39%
391,438 $11.7 Million
Q4 2019

Feb 14, 2020
BUY
$32.75 - $41.43 $371,385 - $469,816
11,340 Added 425.84%
14,003 $482,000
Q3 2019

Nov 14, 2019
BUY
$33.73 - $46.27 $77,275 - $106,004
2,291 Added 615.86%
2,663 $90,000
Q2 2019

Aug 14, 2019
SELL
$29.6 - $40.93 $1,539 - $2,128
-52 Reduced 12.26%
372 $15,000
Q1 2019

May 10, 2019
SELL
$27.85 - $38.09 $1.7 Million - $2.33 Million
-61,065 Reduced 99.31%
424 $13,000
Q3 2018

Nov 13, 2018
SELL
$35.69 - $47.65 $312,680 - $417,461
-8,761 Reduced 12.47%
61,489 $2.4 Million
Q2 2018

Aug 10, 2018
BUY
$28.41 - $42.41 $2 Million - $2.98 Million
70,250 New
70,250 $2.6 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email